Advanced search
Publication Cover
Scandinavian Journal of Rheumatology Volume 17, 1988 - Issue 4
Submit an article Journal homepage
9
Views
5
CrossRef citations to date
0
Altmetric
Original Article

Enhancement of Protein Kinase C-mediated EGF Receptor Phosphorylation by Auranofin

M. Froscio Department of Medical Biochemistry, School of Medicine, Woodville, South Australia, 5011
,
A. W. Murray School of Biological Sciences, Flinders University of South Australia, Bedford Park, South Australia, 5042
&
N. P. Hurst Rheumatology Unit, Queen Elizabeth Hospital, Woodville, South Australia, 5011
Pages 281-285 | Received 19 Aug 1987, Published online: 12 Jul 2009

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Manfred Harth, Keith Cousin & Glenn A. McCain. (1990) In Vitro Effects of two Gold Compounds, and D-Penicillamine on the Producn of Interferon Gamma. Immunopharmacology and Immunotoxicology 12:1, pages 39-60.
Read now

Articles from other publishers (4)

Shuying Shen, Jie Shen, Zhong Luo, Fudi Wang & Junxia Min. (2023) Molecular mechanisms and clinical implications of the gold drug auranofin. Coordination Chemistry Reviews 493, pages 215323.
Crossref
Xiaodong Chen, Radouil Tzekov, Mingyang Su, Haiyan Hong, Wang Min, Aidong Han & Wensheng Li. (2016) Auranofin Inhibits Retinal Pigment Epithelium Cell Survival through Reactive Oxygen Species-Dependent Epidermal Growth Factor Receptor/ Mitogen-Activated Protein Kinase Signaling Pathway. PLOS ONE 11:11, pages e0166386.
Crossref
Jan Bondeson. (1997) The mechanisms of action of disease-modifying antirheumatic drugs: A review with emphasis on macrophage signal transduction and the induction of proinflammatory cytokines. General Pharmacology: The Vascular System 29:2, pages 127-150.
Crossref
Mario Froscio, Andrew W. Murray & Nigel P. Hurst. (1989) Inhibition of protein kinase C activity by the antirheumatic drug auranofin. Biochemical Pharmacology 38:13, pages 2087-2089.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.